P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA

ABSTRACT:

SUBMITTER: Leabman M 

PROVIDER: S-EPMC9429641 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature